
Ophthalmic Immune-Related Adverse Events of Immunotherapy: A Single-Site Case Series.
Publication
, Journal Article
Kim, JM; Materin, MA; Sznol, M; Kluger, HM; Weiss, S; Chow, J; Stoessel, K; Kombo, N; Del Priore, L; Pointdujour-Lim, R
Published in: Ophthalmology
July 2019
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Ophthalmology
DOI
EISSN
1549-4713
Publication Date
July 2019
Volume
126
Issue
7
Start / End Page
1058 / 1062
Location
United States
Related Subject Headings
- Ophthalmology & Optometry
- Nivolumab
- Neoplasms
- Middle Aged
- Male
- Ipilimumab
- Immunotherapy
- Immunologic Factors
- Humans
- Female
Citation
APA
Chicago
ICMJE
MLA
NLM
Kim, J. M., Materin, M. A., Sznol, M., Kluger, H. M., Weiss, S., Chow, J., … Pointdujour-Lim, R. (2019). Ophthalmic Immune-Related Adverse Events of Immunotherapy: A Single-Site Case Series. Ophthalmology, 126(7), 1058–1062. https://doi.org/10.1016/j.ophtha.2019.01.031
Kim, Jenna May, Miguel A. Materin, Mario Sznol, Harriet M. Kluger, Sarah Weiss, Jessica Chow, Kathleen Stoessel, Ninani Kombo, Lucian Del Priore, and Renelle Pointdujour-Lim. “Ophthalmic Immune-Related Adverse Events of Immunotherapy: A Single-Site Case Series.” Ophthalmology 126, no. 7 (July 2019): 1058–62. https://doi.org/10.1016/j.ophtha.2019.01.031.
Kim JM, Materin MA, Sznol M, Kluger HM, Weiss S, Chow J, et al. Ophthalmic Immune-Related Adverse Events of Immunotherapy: A Single-Site Case Series. Ophthalmology. 2019 Jul;126(7):1058–62.
Kim, Jenna May, et al. “Ophthalmic Immune-Related Adverse Events of Immunotherapy: A Single-Site Case Series.” Ophthalmology, vol. 126, no. 7, July 2019, pp. 1058–62. Pubmed, doi:10.1016/j.ophtha.2019.01.031.
Kim JM, Materin MA, Sznol M, Kluger HM, Weiss S, Chow J, Stoessel K, Kombo N, Del Priore L, Pointdujour-Lim R. Ophthalmic Immune-Related Adverse Events of Immunotherapy: A Single-Site Case Series. Ophthalmology. 2019 Jul;126(7):1058–1062.

Published In
Ophthalmology
DOI
EISSN
1549-4713
Publication Date
July 2019
Volume
126
Issue
7
Start / End Page
1058 / 1062
Location
United States
Related Subject Headings
- Ophthalmology & Optometry
- Nivolumab
- Neoplasms
- Middle Aged
- Male
- Ipilimumab
- Immunotherapy
- Immunologic Factors
- Humans
- Female